1Burris HA,Moore MJ,Anderson J,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas: a randomized trial [ J ]. J Clin Oncol, 1997,15 : 2403 - 2413.
3Hainsworth JD, Burris HA, Erland JB, et al. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer[ J]. J Clin Oneol, 1998,16:2164 - 2168.
7Kim YH, Shin SW, Kim BS, et al. Paclitaxel,5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[ J]. Cancer, 1999,85:295 - 301.
8Murad AM, Petroianu A, Guimaraer RC, et al. Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen [ J ]. Am J Oncol, 1999,22:580 - 586.
9Hainsworth J D, Burris H A, Erland J B, et al. Phase Ⅰ study of docetaxel administered by weekly infusion in patients with advanced refractory cancer [J]. J Clin Oncol,1998,16:2164-2168.
10Findlay M, Cunningham D, Norman A, et al. A Phase Ⅱ study in advancedgastroesophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluo-rouracil(ECF) [J]. Annals Oncol, 1994 5: 609-613.
